The removal of m6A is mediated by m6A erasers FTO and ALKBH5, which reverse methylation to destabilize mRNA or alter its translational potential, thereby impacting stem cell fate, DNA damage response, and metabolic reprogramming in cancer 83(Figure 2). Here, FTO is linked to cancer.